Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 70

1.

Expression of FFAR2 by Dendritic Cells Prevents Their Expression of IL27 and is Required For Maintenance of Mucosal Barrier and Immune Response Against Colorectal Tumors in Mice.

Lavoie S, Chun E, Bae S, Brennan CA, Gallini Comeau CA, Lang JK, Michaud M, Hoveyda HR, Fraser GL, Fuller MH, Layden BT, Glickman JN, Garrett WS.

Gastroenterology. 2020 Jan 6. pii: S0016-5085(20)30007-X. doi: 10.1053/j.gastro.2019.12.027. [Epub ahead of print]

PMID:
31917258
2.

The olfactory G protein-coupled receptor (Olfr-78/OR51E2) modulates the intestinal response to colitis.

Kotlo K, Anbazhagan AN, Priyamvada S, Jayawardena D, Kumar A, Chen Y, Xia Y, Finn PW, Perkins DL, Dudeja PK, Layden B.

Am J Physiol Cell Physiol. 2020 Jan 8. doi: 10.1152/ajpcell.00454.2019. [Epub ahead of print]

PMID:
31913697
3.

Acetate coordinates neutrophil and ILC3 responses against C. difficile through FFAR2.

Fachi JL, Sécca C, Rodrigues PB, Mato FCP, Di Luccia B, Felipe JS, Pral LP, Rungue M, Rocha VM, Sato FT, Sampaio U, Clerici MTPS, Rodrigues HG, Câmara NOS, Consonni SR, Vieira AT, Oliveira SC, Mackay CR, Layden BT, Bortoluci KR, Colonna M, Vinolo MAR.

J Exp Med. 2020 Mar 2;217(3). pii: e20190489. doi: 10.1084/jem.20190489.

PMID:
31876919
4.

Sodium-glucose co-transporter 2 inhibitors and the risk of fractures: A propensity score-matched cohort study.

Adimadhyam S, Lee TA, Calip GS, Smith Marsh DE, Layden BT, Schumock GT.

Pharmacoepidemiol Drug Saf. 2019 Dec;28(12):1629-1639. doi: 10.1002/pds.4900. Epub 2019 Oct 24.

PMID:
31646732
5.

Metabolite-Sensing Receptor Ffar2 Regulates Colonic Group 3 Innate Lymphoid Cells and Gut Immunity.

Chun E, Lavoie S, Fonseca-Pereira D, Bae S, Michaud M, Hoveyda HR, Fraser GL, Gallini Comeau CA, Glickman JN, Fuller MH, Layden BT, Garrett WS.

Immunity. 2019 Nov 19;51(5):871-884.e6. doi: 10.1016/j.immuni.2019.09.014. Epub 2019 Oct 15.

PMID:
31628054
6.

Predictors of Obesity among Gut Microbiota Biomarkers in African American Men with and without Diabetes.

Barengolts E, Green SJ, Chlipala GE, Layden BT, Eisenberg Y, Priyadarshini M, Dugas LR.

Microorganisms. 2019 Sep 5;7(9). pii: E320. doi: 10.3390/microorganisms7090320.

7.

The human microbiota is associated with cardiometabolic risk across the epidemiologic transition.

Fei N, Bernabé BP, Lie L, Baghdan D, Bedu-Addo K, Plange-Rhule J, Forrester TE, Lambert EV, Bovet P, Gottel N, Riesen W, Korte W, Luke A, Kliethermes SA, Layden BT, Gilbert JA, Dugas LR.

PLoS One. 2019 Jul 24;14(7):e0215262. doi: 10.1371/journal.pone.0215262. eCollection 2019.

8.

Oxytocin alterations and neurocognitive domains in patients with hypopituitarism.

Eisenberg Y, Murad S, Casagrande A, McArthur M, Dugas LR, Barengolts E, Layden BT.

Pituitary. 2019 Apr;22(2):105-112. doi: 10.1007/s11102-019-00936-0.

PMID:
30656597
9.

Hepatic hexokinase domain containing 1 (HKDC1) improves whole body glucose tolerance and insulin sensitivity in pregnant mice.

Khan MW, Priyadarshini M, Cordoba-Chacon J, Becker TC, Layden BT.

Biochim Biophys Acta Mol Basis Dis. 2019 Mar 1;1865(3):678-687. doi: 10.1016/j.bbadis.2018.11.022. Epub 2018 Dec 10.

PMID:
30543855
10.

Hepatic HKDC1 Expression Contributes to Liver Metabolism.

Pusec CM, De Jesus A, Khan MW, Terry AR, Ludvik AE, Xu K, Giancola N, Pervaiz H, Daviau Smith E, Ding X, Harrison S, Chandel NS, Becker TC, Hay N, Ardehali H, Cordoba-Chacon J, Layden BT.

Endocrinology. 2019 Feb 1;160(2):313-330. doi: 10.1210/en.2018-00887.

11.

Gut microbial features can predict host phenotype response to protein deficiency.

Navarro G, Sharma A, Dugas LR, Forrester T, Gilbert JA, Layden BT.

Physiol Rep. 2018 Dec;6(23):e13932. doi: 10.14814/phy2.13932.

12.

Decreased microbial co-occurrence network stability and SCFA receptor level correlates with obesity in African-origin women.

Dugas LR, Bernabé BP, Priyadarshini M, Fei N, Park SJ, Brown L, Plange-Rhule J, Nelson D, Toh EC, Gao X, Dong Q, Sun J, Kliethermes S, Gottel N, Luke A, Gilbert JA, Layden BT.

Sci Rep. 2018 Nov 20;8(1):17135. doi: 10.1038/s41598-018-35230-9.

13.

More evening preference is positively associated with systemic inflammation in prediabetes and type 2 diabetes patients.

Nimitphong H, Mahattanapreut A, Chailurkit LO, Saetung S, Siwasaranond N, Sumritsopak R, Anothaisintawee T, Thakkinstian A, Dugas LR, Layden BT, Reutrakul S.

Sci Rep. 2018 Oct 26;8(1):15882. doi: 10.1038/s41598-018-34045-y.

14.

Increased risk of mycotic infections associated with sodium-glucose co-transporter 2 inhibitors: a prescription sequence symmetry analysis.

Adimadhyam S, Schumock GT, Calip GS, Smith Marsh DE, Layden BT, Lee TA.

Br J Clin Pharmacol. 2019 Jan;85(1):160-168. doi: 10.1111/bcp.13782. Epub 2018 Nov 8.

15.

Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition: the METS-Microbiome study protocol.

Dugas LR, Lie L, Plange-Rhule J, Bedu-Addo K, Bovet P, Lambert EV, Forrester TE, Luke A, Gilbert JA, Layden BT.

BMC Public Health. 2018 Aug 6;18(1):978. doi: 10.1186/s12889-018-5879-6.

16.

Role of Short Chain Fatty Acid Receptors in Intestinal Physiology and Pathophysiology.

Priyadarshini M, Kotlo KU, Dudeja PK, Layden BT.

Compr Physiol. 2018 Jun 18;8(3):1091-1115. doi: 10.1002/cphy.c170050. Review.

17.

Risk of amputations associated with SGLT2 inhibitors compared to DPP-4 inhibitors: A propensity-matched cohort study.

Adimadhyam S, Lee TA, Calip GS, Smith Marsh DE, Layden BT, Schumock GT.

Diabetes Obes Metab. 2018 Dec;20(12):2792-2799. doi: 10.1111/dom.13459. Epub 2018 Aug 5.

PMID:
29971914
18.

Autophagy Differentially Regulates Insulin Production and Insulin Sensitivity.

Yamamoto S, Kuramoto K, Wang N, Situ X, Priyadarshini M, Zhang W, Cordoba-Chacon J, Layden BT, He C.

Cell Rep. 2018 Jun 12;23(11):3286-3299. doi: 10.1016/j.celrep.2018.05.032.

19.

Gut Microbiota: FFAR Reaching Effects on Islets.

Priyadarshini M, Navarro G, Layden BT.

Endocrinology. 2018 Jun 1;159(6):2495-2505. doi: 10.1210/en.2018-00296. Review.

20.

The Association of Dietary Fiber Intake with Cardiometabolic Risk in Four Countries across the Epidemiologic Transition.

Lie L, Brown L, Forrester TE, Plange-Rhule J, Bovet P, Lambert EV, Layden BT, Luke A, Dugas LR.

Nutrients. 2018 May 16;10(5). pii: E628. doi: 10.3390/nu10050628.

Supplemental Content

Loading ...
Support Center